Whole-Room Calorimeter
Whole-Room Calorimeter
批准号:
10431445
负责人:
ARLENE B CHAPMAN
金额:
$128.4万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2022
资助国家:
美国
项目状态:
已结题
起止时间:
2022-09-15 至 2024-09-14
关键词:
AdvocateAnorexiaBody Weight decreasedChicagoChronic Kidney FailureCitiesComplexCongestive Heart FailureControlled EnvironmentDiabetes MellitusDiseaseEatingEnergy MetabolismEquipmentFamilyFoodFundingGoldHeadHealthHospitalsHourIllinoisInflammatory Bowel DiseasesInstitutesInstitutionInvestigationKidney DiseasesLifeLong COVIDMeasurementMeasuresMedicalMetabolicMetabolic syndromeMetabolismMichiganObesityPatientsPhysical activityResearchResearch PersonnelRestRoleSiteSleepTechnologyThyroid DiseasesThyroid Function TestsUnited States National Institutes of HealthUniversitiesWisconsinbasecircadiancircadian biologydoubly-labeled waterexperiencefrailtyinstrumentationmicrobiomenutritionprogramsstandard measuretranslational medicine
中文摘要
摘要
英文摘要
Abstract
The Institute for Translational Medicine (ITM) at the University of Chicago (UChicago) proposes to purchase and
install a large and flex indirect calorimeter (IC) to support leading research programs in metabolism, diabetes,
obesity, disorders of thyroid function, the microbiome, inflammatory bowel disease, weight reduction, frailty,
circadian biology, and kidney disorders, among others. IC is the gold standard for measuring energy expenditure
(EE) providing precise and accurate measures under regulated environmental conditions, ranging from maximal
physical activity to sleep (SMR). For over 15 years UChicago investigators have measured EE using metabolic
carts and doubly-labelled water, which only measures resting EE or RMR, for a limited duration (maximum 4
hours), requiring an over-the-head hood placement, limiting free mobility and with less precision than IC. Despite
these limitations, UChicago NIH-funded investigators have incorporated measures of EE since 2004 resulting in
highly impactful scientific findings. The IC proposed in this application is the only equipment available for long
term (24hrs or more) EE measurements, that can determine circadian EE (ie RMR vs. SMR) with strictly
controlled environmental conditions while aspects of daily life are evaluated including eating or thermal effects
of food (TEF), sleeping (SMR) and physical activity. With the establishment of the Microbiome Center in 2015
and the Duchossois Family Institute in 2017 at UChicago, world-leading programs in the microbiome in health
and disease are now being established. There is strong evidence for the impact of the microbiome on EE in a
variety of complex medical disorders such as obesity, anorexia, metabolic syndrome, diabetes, circadian biology,
chronic kidney disease, post COVID 19 syndromes, congestive heart failure and inflammatory bowel disease.
However, EE changes associated with these disorders are nuanced and limitations in precision and accuracy
require better instrumentation. Use of the IC proposed in this application will help to optimize patient long-term
health in a variety of medical settings. By having capacity for IC measurement of EE while collecting biofluids
simultaneously in a controlled environment, the contributory roles of the microbiome, metabolism and circadian
biology can be characterized. Through the ITM, a multi-institution CTSA program partnered with Rush University
and affiliated with Loyola University, Northshore Hospital, Advocate Center and the Illinois Institute for
Technology, city-wide utilization of the IC will be facilitated and supported. Investigators from other Chicago-
based institutions including Northwestern University and University of Illinois, and regional or great lakes such
as University of Wisconsin and the Nutrition Obesity Research Center (NORC) investigators from University of
Michigan, will perform scientific investigations. Seminars with experienced investigators in EE from other sites
will advance and disseminate scientific findings from this center and advance multiple fields forward.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
MRI Risk Classification in Children and Young Adults with ADPKD
-
批准号:10673378
-
项目类别:
-
资助金额:$10.0万
-
财政年份:2022
-
负责人:ARLENE B CHAPMAN
-
依托单位:
Limited Competition for the Continuation of the Consortium for Radiologic Imaging
-
批准号:9274682
-
项目类别:
-
资助金额:$6.0万
-
财政年份:2016
-
负责人:ARLENE B CHAPMAN
-
依托单位:
Limited Competition for the Continuation of the Consortium for Radiologic Imaging
-
批准号:9044528
-
项目类别:
-
资助金额:$33.15万
-
财政年份:2015
-
负责人:ARLENE B CHAPMAN
-
依托单位:
Limited Competition: Clinical Centers for the HALT-Polycystic Kidney Disease Tria
-
批准号:7920518
-
项目类别:
-
资助金额:$11.01万
-
财政年份:2009
-
负责人:ARLENE B CHAPMAN
-
依托单位:
GENETIC EPIDEMIOLOGY OF BLOOD PRESSURE RESPONSE TO ANGIOTENSIN RECEPTOR BLOCKER
-
批准号:7603688
-
项目类别:
-
资助金额:$2.54万
-
财政年份:2006
-
负责人:ARLENE B CHAPMAN
-
依托单位:
HALT PROGRESSION OF POLYCYSTIC KIDNEY DISEASE
-
批准号:7603623
-
项目类别:
-
资助金额:$4.16万
-
财政年份:2006
-
负责人:ARLENE B CHAPMAN
-
依托单位:
PHARMACOGENETIC EVALUATION OF ANTI-HYPERTENSIVE RESPONSE (PEAR)
-
批准号:7603690
-
项目类别:
-
资助金额:$3.2万
-
财政年份:2006
-
负责人:ARLENE B CHAPMAN
-
依托单位:
THE ADPKD COHORT STUDY
-
批准号:7603645
-
项目类别:
-
资助金额:$0.13万
-
财政年份:2006
-
负责人:ARLENE B CHAPMAN
-
依托单位:
GERA-2 STUDY
-
批准号:7603656
-
项目类别:
-
资助金额:$0.64万
-
财政年份:2006
-
负责人:ARLENE B CHAPMAN
-
依托单位:
HALT-PKD
-
批准号:7603689
-
项目类别:
-
资助金额:$0.83万
-
财政年份:2006
-
负责人:ARLENE B CHAPMAN
-
依托单位:
ADPKD COHORT STUDY
-
批准号:7376427
-
项目类别:
-
资助金额:$1.21万
-
财政年份:2005
-
负责人:ARLENE B CHAPMAN
-
依托单位:
GENETIC EPIDEMIOLOGY OF BLOOD PRESSURE RESPONSE TO ANGIOTENSIN RECEPTOR BLOCKER
-
批准号:7376428
-
项目类别:
-
资助金额:$8.8万
-
财政年份:2005
-
负责人:ARLENE B CHAPMAN
-
依托单位:
GERA-2 STUDY
-
批准号:7198980
-
项目类别:
-
资助金额:$15.97万
-
财政年份:2005
-
负责人:ARLENE B CHAPMAN
-
依托单位:
ADPKD COHORT STUDY
-
批准号:7198995
-
项目类别:
-
资助金额:$1.74万
-
财政年份:2005
-
负责人:ARLENE B CHAPMAN
-
依托单位:
PHARMACOGENETIC EVALUATION OF ANTI-HYPERTENSIVE RESPONSE (PEAR)
-
批准号:7376386
-
项目类别:
-
资助金额:$0.1万
-
财政年份:2005
-
负责人:ARLENE B CHAPMAN
-
依托单位:
GERA-2 STUDY
-
批准号:7376413
-
项目类别:
-
资助金额:$0.12万
-
财政年份:2005
-
负责人:ARLENE B CHAPMAN
-
依托单位:
CRISP STUDY
-
批准号:7198974
-
项目类别:
-
资助金额:$8.81万
-
财政年份:2005
-
负责人:ARLENE B CHAPMAN
-
依托单位:
GERA-2 STUDY
-
批准号:7198996
-
项目类别:
-
资助金额:$11.84万
-
财政年份:2005
-
负责人:ARLENE B CHAPMAN
-
依托单位:
ENDOTHELIAL FUNCTION IN PATIENTS WITH AUTOSOMAL POLYCYSTIC KIDNEY DISEASE
-
批准号:7376406
-
项目类别:
-
资助金额:$0.02万
-
财政年份:2005
-
负责人:ARLENE B CHAPMAN
-
依托单位:
THE ADPKD COHORT STUDY
-
批准号:7198969
-
项目类别:
-
资助金额:$19.08万
-
财政年份:2005
-
负责人:ARLENE B CHAPMAN
-
依托单位:
海外基金